Ignite Creation Date:
2024-05-06 @ 1:05 PM
Last Modification Date:
2024-10-26 @ 1:08 PM
Study NCT ID:
NCT03929666
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-06
First Post:
2019-02-22
Brief Title:
A Safety and Efficacy Study of ZW25 Zanidatamab Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers Including Gastroesophageal Adenocarcinoma Biliary Tract Cancer and Colorectal Cancer
Sponsor:
Jazz Pharmaceuticals
Organization:
Jazz Pharmaceuticals
Organization Data
Organization:
Jazz Pharmaceuticals
Class:
INDUSTRY
Study ID:
ZWI-ZW25-201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Jazz Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None